Skip to main content

Caxton Corp

SEC CIK
0001388551
Latest filing
Aug 13, 2026

ACRS holding history

Aclaris Therapeutics, Inc. in every 13F filed by Caxton Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACRS overviewAll 13F holders of ACRSFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2023
Holdings of ACRS by Caxton Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−19,473−100.0%Sold outHolders
Q3 202319,473$133.4K0.5%+19,473NewHolders